On Tuesday, Hoth Therapeutics Inc (NASDAQ: HOTH) opened higher 4.49% from the last session, before settling in for the closing price of $1.23. Price fluctuations for HOTH have ranged from $0.58 to $3.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 27.96% over the past five years. Company’s average yearly earnings per share was noted 65.62% at the time writing. With a float of $13.14 million, this company’s outstanding shares have now reached $13.17 million.
Let’s look at the performance matrix of the company that is accounted for 6 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Hoth Therapeutics Inc (HOTH) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Hoth Therapeutics Inc is 0.49%, while institutional ownership is 2.30%. The most recent insider transaction that took place on Aug 16 ’24, was worth 16,750. In this transaction CEO and President of this company bought 25,000 shares at a rate of $0.67, taking the stock ownership to the 58,131 shares.
Hoth Therapeutics Inc (HOTH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 65.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.90% during the next five years compared to 27.96% growth over the previous five years of trading.
Hoth Therapeutics Inc (NASDAQ: HOTH) Trading Performance Indicators
Check out the current performance indicators for Hoth Therapeutics Inc (HOTH). In the past quarter, the stock posted a quick ratio of 15.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Hoth Therapeutics Inc (HOTH)
Hoth Therapeutics Inc (NASDAQ: HOTH) saw its 5-day average volume 1.14 million, a negative change from its year-to-date volume of 5.23 million. As of the previous 9 days, the stock’s Stochastic %D was 37.53%.
During the past 100 days, Hoth Therapeutics Inc’s (HOTH) raw stochastic average was set at 55.36%, which indicates a significant increase from 44.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 250.91% in the past 14 days, which was higher than the 128.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9837, while its 200-day Moving Average is $0.9963. Nevertheless, the first resistance level for the watch stands at $1.3499 in the near term. At $1.4199, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4998. If the price goes on to break the first support level at $1.2000, it is likely to go to the next support level at $1.1201. The third support level lies at $1.0501 if the price breaches the second support level.
Hoth Therapeutics Inc (NASDAQ: HOTH) Key Stats
There are currently 13,209K shares outstanding in the company with a market cap of 16.91 million. Presently, the company’s annual sales total 0 K according to its annual income of -8,190 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,480 K.
